Local/systemic reactogenicity was assessed the day of vaccination and for 6days thereafter. Top1 inhibitor 1 third dose, and 45 received a fourth dose of NVX-CoV2373. The incidence of local/systemic reactogenicity events increased after the first three doses of NVX-CoV2373 and leveled off after dose 4. Unsolicited AEs were reported in Continue Reading